Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.


TSX:KSI - Post by User

Bullboard Posts
Post by Empire82on Feb 26, 2020 1:27am
113 Views
Post# 30733937

Nice sell off

Nice sell off

This is a buying opportunity if this sell off continues imo. If you run the numbers here you will see how huge of the potential there is here. 

4000 estimate sites
20-50 licenses per site
5000 per license

Seeing how KSI's software works  and they are landing the largest pharma companies in the world what would be a realistic market share for KSI to capture? 10%, 20%, 30%?

10% of sites landed = 400 sites * 20 licenses * 5000 = 40 million revenue * 6x sales multiple = $4
20% of sites landed = 800 sites * 20 licenses * 5000 = 80 million revenue * 6x sales multiple = $8
30% of sites landed = 1200 sites * 20 licenes * 5000 = 120 million revenue * 6x sales multiple = $12

This is the potential I see here over the next few years. If they get on the Nasdaq the multiple would be higher

Bullboard Posts